Stockreport

Tumor-Induced Osteomalacia Market Size to Grow USD 153 Million by 2034, With a CAGR of 2.6%| Polaris Market Research [Yahoo! Finance]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF The global tumor-induced osteomalacia market size was USD 118.25 million in 2024, estimated at USD 121.12 million in 2025, and is expected to reach around USD 153.00 mi [Read more]